Dr. Simon has worked with CHS for 14 years, assuming the CMO role in 2017. Effective Jan. 1, she will transition into a consulting position focused on cultivating new partnerships and advising the system’s management team on efforts to enhance innovation across care delivery, patient experience and clinician workflows, according to a Sept. 11 news release.
Dr. Simon is behind many partnerships that have led to better outcomes for patients and more streamlined workflows for clinicians, CHS leaders said in sharing the news of her transition. She played a key role in establishing the health system’s partnership with Mark Cuban Cost Plus Drugs, with the pharmaceutical company serving as a wholesale drug distributor for CHS ‘ 71 hospitals.
Once Dr. Simon transitions to the consulting arrangement, Miguel Benet, MD, will become president of clinical operations and CMO. He is currently the executive vice president of clinical operations.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
